Journal of the American Academy of Child & Adolescent Psychiatry
Clinical reviewAssessment and Management of Sleep Problems in Youths With Attention-Deficit/Hyperactivity Disorder
Section snippets
Method
PubMed, Ovid, EMBASE, and Web of Knowledge were searched from their inception to October 31, 2012 (search strategy available from corresponding author). We opted not to search for unpublished, non–peer-reviewed data because, as pointed out by the Cochrane group,6 the inclusion of unpublished data may introduce bias. Grades of evidence for recommendation on the management of sleep problems were assessed using the Scottish Intercollegiate Guidelines Network (SIGN) system (http://www.sign.ac.uk/).
Literature Search Results
After selection, 139 original articles were retained, including 22 papers on treatment (Figure 1). Building on this body of evidence, the following sections present our recommendations, preceded by an introductory section on sleep problems in youths with ADHD.
Sleep Problems in Youths With ADHD
As many as 70% of children with ADHD have been reported to display mild to severe sleep problems.8 Prevalence rates differ as a function of ADHD subtype (highest prevalence in the combined subtype,9 although sleepiness may be more frequent in the inattentive subtype5), psychiatric comorbidities, and medication use (both increasing the prevalence of sleep problems)9.
The most recent meta-analysis on sleep in ADHD10 found that children and/or their parents reported bedtime resistance, sleep-onset
Assessment of Sleep Problems in Children With ADHD in the Mental Health Setting
We recommend a baseline sleep evaluation during the initial assessment of ADHD as well as regular systematic screening for sleep problems as a necessary component of ongoing ADHD care. Although this review focuses on the management of sleep problems in children with an established diagnosis of ADHD, it is important to bear in mind that sleep disorders may mimic ADHD symptoms. Therefore, it is fundamental to screen for sleep disorders also in children referred for ADHD-like symptoms who do not
Behaviorally Based Insomnia
(Note: Because the term “behavioral insomnia” will disappear from the next edition of the ICSD, here “insomnia” refers to sleep-onset association and limit-setting disorders [Table 1]).
If impairing symptoms of insomnia are reported during the screening phase, a 2-week sleep diary should be kept to more clearly identify behaviors and patterns associated with insomnia (for diagnostic criteria of insomnia, see the American Acedemy of Sleep Medicine criteria13). Because individuals with ADHD may
Management of Sleep Problems in Children With ADHD
Management of sleep problems in children/youth with ADHD needs to be tailored to the specific conditions underlying sleep complaints. Before discussing the specific management of such conditions, we present a section on healthy sleep practices, the implementation of which should precede the targeted management of specific sleep disorders/conditions.
Tips for Adolescents and Young Adults
Several factors (e.g., hormonal, emotional, and social) make sleep problems in adolescents and young adults more problematic than in younger children. One factor that may contribute to sleep problems of adolescents and young adults is use of electronic media. Another factor that may complicate sleep and exacerbate arousal problems in this population is substance use. Some adolescents with ADHD report that they frequently make use of marijuana before bedtime to help them relax and fall asleep
References (59)
- et al.
A framework for the assessment and treatment of sleep problems in children with attention-deficit/hyperactivity disorder
Pediatr Clin North Am
(2011) - et al.
Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
Use of the ‘BEARS’ sleep screening tool in a pediatric residents' continuity clinic: a pilot study
Sleep Med
(2005) - et al.
Instability of sleep patterns in children with attention-deficit/hyperactivity disorder
J Am Acad Child Adolesc Psychiatry
(2000) - et al.
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
Sleep Med
(2003) - et al.
Advances in pediatric restless legs syndrome: iron, genetics, diagnosis and treatment
Sleep Med
(2010) - et al.
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups
J Am Acad Child Adolesc Psychiatry
(2001) - et al.
Peri-sleep-onset cortisol levels in children and adolescents with affective disorders
Biol Psychiatry
(2006) - et al.
ADHD treatments, sleep, and sleep problems: complex associations
Neurotherapeutics
(2012) - et al.
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia
J Am Acad Child Adolesc Psychiatry
(2006)
Managing sleep problems in school aged children with ADHD: a pilot randomised controlled trial
Sleep Med
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia
J Am Acad Child Adolesc Psychiatry
Pharmacological management of treatment-induced insomnia in ADHD
J Am Acad Child Adolesc Psychiatry
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases
J Am Acad Child Adolesc Psychiatry
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder
J Am Acad Child Adolesc Psychiatry
DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy
J Am Acad Child Adolesc Psychiatry
Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study
Sleep Med
Effects of iron supplementation on attention deficit hyperactivity disorder in children
Pediatr Neurol
l-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children
Sleep Med
Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group
Pediatr Neurol
Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome
Pediatr Neurol
Restless leg syndrome in ADHD children: levetiracetam as a reasonable therapeutic option
Brain Dev
Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies
Am J Psychiatry
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents
Pediatrics
Pediatric sleep medicine: priorities for research, patient care, policy and education
J Clin Sleep Med
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
BMJ
Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family
Arch Pediatr Adolesc Med
Cited by (169)
Sleep and Circadian Disturbances in Children With Neurodevelopmental Disorders
2023, Seminars in Pediatric NeurologyAdolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders
2023, Psychiatric Clinics of North AmericaThe Italian contribution to pediatric sleep medicine: A scientometric analysis
2023, Sleep MedicineLinks between excessive daytime sleepiness and EEG power and activation in two subtypes of ADHD
2023, Biological Psychology
This article was reviewed under and accepted by ad hoc editor James J. Hudziak, M.D.
This Consensus Conference was supported by an unrestricted educational grant from Shire Pharmaceuticals. Dr. Cortese is supported by a Marie Curie International Outgoing Fellowship (PIOF-253103) from the European Commission Research Executive Agency.
The authors are very grateful to Mara Pasetto of CtpVerona for her assistance with figure editing.
Clinical guidance is available at the end of this article.
Disclosure: Dr. Brown has received research support from Eli Lilly and Co. and from Shire. Dr. Stein has received support from Shire and has served as a consultant to Novartis and Next Wave Pharmaceuticals. Dr. Weiss has received honoraria, speaker board fees, research funds, and consultant fees from Eli Lilly and Co., Janssen, Purdue, and Shire. Dr. Owens has received grants from UCB; has served as a consultant to Takeda, Purdue, UCB, Transcept, and Shire; and has served on the advisory board of Jazz. Drs. Cortese, Corkum, Gruber, and O’Brien report no biomedical financial interests or potential conflicts of interest.